We report here that Smad7, a classical TGF-β target gene so far recognized mainly as a negative regulator of TGF-β signaling, also can act in the nucleus as a positive regulator of transcription of two tumor-promoting genes, which are linked to tumor invasion. The gene discussed is SMAD7; the disease is neoplasm.